Global and Japan Drug-Eluting Bioabsorbable Stents Market Insights, Forecast to 2026

Publisher Name :
Date: 21-Sep-2020
No. of pages: 142
Inquire Before Buying

Drug-Eluting Bioabsorbable Stents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Eluting Bioabsorbable Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Drug-Eluting Bioabsorbable Stents market is segmented into

- Serolimus and Paclitaxel Drug-Eluting Stents

- Sirolimus Drug Eluting Stents

Segment by Application, the Drug-Eluting Bioabsorbable Stents market is segmented into

- Coronary Artery Diseases

- Peripheral Artery Diseases

Regional and Country-level Analysis

The Drug-Eluting Bioabsorbable Stents market is analysed and market size information is provided by regions (countries).

The key regions covered in the Drug-Eluting Bioabsorbable Stents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Drug-Eluting Bioabsorbable Stents Market Share Analysis

Drug-Eluting Bioabsorbable Stents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug-Eluting Bioabsorbable Stents business, the date to enter into the Drug-Eluting Bioabsorbable Stents market, Drug-Eluting Bioabsorbable Stents product introduction, recent developments, etc.

The major vendors covered:

- Medtronic

- B.Braun Melsungen

- Abbott Laboratories

- Boston Scientific Corporation

- Biosensors International

- Terumo Corporation.

- MicroPort Scientific Corporation

- Alvimedica

- Biotronik

- Elixir Medical Corporation

- Innovative Health Technologies

Global and Japan Drug-Eluting Bioabsorbable Stents Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Drug-Eluting Bioabsorbable Stents Product Introduction
1.2 Market Segments
1.3 Key Drug-Eluting Bioabsorbable Stents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type
1.4.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.4.3 Sirolimus Drug Eluting Stents
1.5 Market by Application
1.5.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application
1.5.2 Coronary Artery Diseases
1.5.3 Peripheral Artery Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drug-Eluting Bioabsorbable Stents Market Size, Estimates and Forecasts
2.1.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2015-2026
2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026
2.2 Global Drug-Eluting Bioabsorbable Stents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Drug-Eluting Bioabsorbable Stents Historical Market Size by Region (2015-2020)
2.3.1 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2021-2026)
2.4.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2021-2026)
3 Global Drug-Eluting Bioabsorbable Stents Competitor Landscape by Players
3.1 Global Top Drug-Eluting Bioabsorbable Stents Sales by Manufacturers
3.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020)
3.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2015-2020)
3.2 Global Drug-Eluting Bioabsorbable Stents Manufacturers by Revenue
3.2.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020)
3.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drug-Eluting Bioabsorbable Stents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drug-Eluting Bioabsorbable Stents Revenue in 2019
3.2.5 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Drug-Eluting Bioabsorbable Stents Price by Manufacturers
3.4 Global Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution, Product Types
3.4.1 Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
3.4.3 Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Type (2015-2020)
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020)
4.1.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2021-2026)
4.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2021-2026)
4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2021-2026)
4.2.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Application (2015-2020)
5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020)
5.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2015-2020)
5.1.3 Drug-Eluting Bioabsorbable Stents Price by Application (2015-2020)
5.2 Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2021-2026)
5.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2021-2026)
5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
6.1.1 Japan Drug-Eluting Bioabsorbable Stents Sales YoY Growth 2015-2026
6.1.2 Japan Drug-Eluting Bioabsorbable Stents Revenue YoY Growth 2015-2026
6.1.3 Japan Drug-Eluting Bioabsorbable Stents Market Share in Global Market 2015-2026
6.2 Japan Drug-Eluting Bioabsorbable Stents Market Size by Players (International and Local Players)
6.2.1 Japan Top Drug-Eluting Bioabsorbable Stents Players by Sales (2015-2020)
6.2.2 Japan Top Drug-Eluting Bioabsorbable Stents Players by Revenue (2015-2020)
6.3 Japan Drug-Eluting Bioabsorbable Stents Historic Market Review by Type (2015-2020)
6.3.1 Japan Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
6.3.2 Japan Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2015-2020)
6.3.3 Japan Drug-Eluting Bioabsorbable Stents Price by Type (2015-2020)
6.4 Japan Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2021-2026)
6.4.2 Japan Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2021-2026)
6.4.3 Japan Drug-Eluting Bioabsorbable Stents Price Forecast by Type (2021-2026)
6.5 Japan Drug-Eluting Bioabsorbable Stents Historic Market Review by Application (2015-2020)
6.5.1 Japan Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
6.5.2 Japan Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2015-2020)
6.5.3 Japan Drug-Eluting Bioabsorbable Stents Price by Application (2015-2020)
6.6 Japan Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2021-2026)
6.6.2 Japan Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2021-2026)
6.6.3 Japan Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2021-2026)
7 North America
7.1 North America Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
7.2 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
7.2.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020)
7.2.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
8.2 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
8.2.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
8.2.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
9.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
9.2.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2015-2020)
9.2.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
10.2 Latin America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
10.2.1 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country
10.2.2 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
11.2.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country
11.2.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Description and Business Overview
12.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
12.1.5 Medtronic Recent Development
12.2 B.Braun Melsungen
12.2.1 B.Braun Melsungen Corporation Information
12.2.2 B.Braun Melsungen Description and Business Overview
12.2.3 B.Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
12.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Products Offered
12.2.5 B.Braun Melsungen Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Corporation Information
12.3.2 Abbott Laboratories Description and Business Overview
12.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Corporation Information
12.4.2 Boston Scientific Corporation Description and Business Overview
12.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.4.5 Boston Scientific Corporation Recent Development
12.5 Biosensors International
12.5.1 Biosensors International Corporation Information
12.5.2 Biosensors International Description and Business Overview
12.5.3 Biosensors International Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Products Offered
12.5.5 Biosensors International Recent Development
12.6 Terumo Corporation.
12.6.1 Terumo Corporation. Corporation Information
12.6.2 Terumo Corporation. Description and Business Overview
12.6.3 Terumo Corporation. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Products Offered
12.6.5 Terumo Corporation. Recent Development
12.7 MicroPort Scientific Corporation
12.7.1 MicroPort Scientific Corporation Corporation Information
12.7.2 MicroPort Scientific Corporation Description and Business Overview
12.7.3 MicroPort Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.7.5 MicroPort Scientific Corporation Recent Development
12.8 Alvimedica
12.8.1 Alvimedica Corporation Information
12.8.2 Alvimedica Description and Business Overview
12.8.3 Alvimedica Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Products Offered
12.8.5 Alvimedica Recent Development
12.9 Biotronik
12.9.1 Biotronik Corporation Information
12.9.2 Biotronik Description and Business Overview
12.9.3 Biotronik Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Products Offered
12.9.5 Biotronik Recent Development
12.10 Elixir Medical Corporation
12.10.1 Elixir Medical Corporation Corporation Information
12.10.2 Elixir Medical Corporation Description and Business Overview
12.10.3 Elixir Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.10.5 Elixir Medical Corporation Recent Development
12.11 Medtronic
12.11.1 Medtronic Corporation Information
12.11.2 Medtronic Description and Business Overview
12.11.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
12.11.5 Medtronic Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Drug-Eluting Bioabsorbable Stents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug-Eluting Bioabsorbable Stents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Drug-Eluting Bioabsorbable Stents Market Segments
Table 2. Ranking of Global Top Drug-Eluting Bioabsorbable Stents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Serolimus and Paclitaxel Drug-Eluting Stents
Table 5. Major Manufacturers of Sirolimus Drug Eluting Stents
Table 6. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Drug-Eluting Bioabsorbable Stents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Drug-Eluting Bioabsorbable Stents Sales by Regions 2015-2020 (K Units)
Table 9. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Regions (2015-2020)
Table 10. Global Drug-Eluting Bioabsorbable Stents Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers (2015-2020)
Table 14. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Drug-Eluting Bioabsorbable Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2019)
Table 16. Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Drug-Eluting Bioabsorbable Stents Price (2015-2020) (USD/Unit)
Table 19. Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
Table 21. Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 24. Global Drug-Eluting Bioabsorbable Stents Sales Share by Type (2015-2020)
Table 25. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2015-2020)
Table 27. Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Drug-Eluting Bioabsorbable Stents Sales Share by Type (2021-2026)
Table 29. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 30. Global Drug-Eluting Bioabsorbable Stents Sales Share by Application (2015-2020)
Table 31. Global Drug-Eluting Bioabsorbable Stents Sales Share by Application (2021-2026)
Table 32. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Drug-Eluting Bioabsorbable Stents Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Drug-Eluting Bioabsorbable Stents Sales Share by Company (2015-2020)
Table 37. Japan Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2015-2020)
Table 39. Japan Drug-Eluting Bioabsorbable Stents Sales Share by Type (2015-2020)
Table 40. Japan Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Drug-Eluting Bioabsorbable Stents Price (K Units) by Type (2015-2020)
Table 42. Japan Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2021-2026)
Table 43. Japan Drug-Eluting Bioabsorbable Stents Sales Share by Type (2021-2026)
Table 44. Japan Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2021-2026)
Table 46. Japan Drug-Eluting Bioabsorbable Stents Price (K Units) by Type (2021-2026)
Table 47. Japan Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application (2015-2020)
Table 48. Japan Drug-Eluting Bioabsorbable Stents Sales Share by Application (2015-2020)
Table 49. Japan Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application (2021-2026)
Table 51. Japan Drug-Eluting Bioabsorbable Stents Sales Share by Application (2021-2026)
Table 52. Japan Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Drug-Eluting Bioabsorbable Stents Revenue Share by Application (2021-2026)
Table 54. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 55. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 56. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 58. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 59. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 60. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020)
Table 66. Latin America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 67. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 74. Medtronic Corporation Information
Table 75. Medtronic Description and Business Overview
Table 76. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Medtronic Drug-Eluting Bioabsorbable Stents Product
Table 78. Medtronic Recent Development
Table 79. B.Braun Melsungen Corporation Information
Table 80. B.Braun Melsungen Description and Business Overview
Table 81. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. B.Braun Melsungen Product
Table 83. B.Braun Melsungen Recent Development
Table 84. Abbott Laboratories Corporation Information
Table 85. Abbott Laboratories Description and Business Overview
Table 86. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Recent Development
Table 89. Boston Scientific Corporation Corporation Information
Table 90. Boston Scientific Corporation Description and Business Overview
Table 91. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Boston Scientific Corporation Product
Table 93. Boston Scientific Corporation Recent Development
Table 94. Biosensors International Corporation Information
Table 95. Biosensors International Description and Business Overview
Table 96. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Biosensors International Product
Table 98. Biosensors International Recent Development
Table 99. Terumo Corporation. Corporation Information
Table 100. Terumo Corporation. Description and Business Overview
Table 101. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Terumo Corporation. Product
Table 103. Terumo Corporation. Recent Development
Table 104. MicroPort Scientific Corporation Corporation Information
Table 105. MicroPort Scientific Corporation Description and Business Overview
Table 106. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. MicroPort Scientific Corporation Product
Table 108. MicroPort Scientific Corporation Recent Development
Table 109. Alvimedica Corporation Information
Table 110. Alvimedica Description and Business Overview
Table 111. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Alvimedica Product
Table 113. Alvimedica Recent Development
Table 114. Biotronik Corporation Information
Table 115. Biotronik Description and Business Overview
Table 116. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Biotronik Product
Table 118. Biotronik Recent Development
Table 119. Elixir Medical Corporation Corporation Information
Table 120. Elixir Medical Corporation Description and Business Overview
Table 121. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Elixir Medical Corporation Product
Table 123. Elixir Medical Corporation Recent Development
Table 124. Innovative Health Technologies Corporation Information
Table 125. Innovative Health Technologies Description and Business Overview
Table 126. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Innovative Health Technologies Product
Table 128. Innovative Health Technologies Recent Development
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Drug-Eluting Bioabsorbable Stents Players
Table 133. Drug-Eluting Bioabsorbable Stents Customers List
Table 134. Drug-Eluting Bioabsorbable Stents Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug-Eluting Bioabsorbable Stents Product Picture
Figure 2. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2020 & 2026
Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents Product Picture
Figure 4. Sirolimus Drug Eluting Stents Product Picture
Figure 5. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2020 & 2026
Figure 6. Coronary Artery Diseases
Figure 7. Peripheral Artery Diseases
Figure 8. Drug-Eluting Bioabsorbable Stents Report Years Considered
Figure 9. Global Drug-Eluting Bioabsorbable Stents Market Size 2015-2026 (US$ Million)
Figure 10. Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026 (K Units)
Figure 11. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020)
Figure 13. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019
Figure 14. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020)
Figure 15. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019
Figure 16. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2019
Figure 18. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Figure 20. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2019
Figure 21. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2015-2020)
Figure 22. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type in 2019
Figure 23. Global Drug-Eluting Bioabsorbable Stents Market Share by Price Range (2015-2020)
Figure 24. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Figure 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2019
Figure 26. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2015-2020)
Figure 27. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application in 2019
Figure 28. Japan Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2026 (K Units)
Figure 29. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. Japan Drug-Eluting Bioabsorbable Stents Market Share in Global Market 2015-2026
Figure 31. Japan 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue in Drug-Eluting Bioabsorbable Stents in 2019
Figure 32. Japan Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2015-2020)
Figure 33. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Japan Drug-Eluting Bioabsorbable Stents Revenue Share by Application (2015-2020)
Figure 35. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 39. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 40. U.S. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 47. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 48. Germany Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019
Figure 61. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019
Figure 62. China Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Drug-Eluting Bioabsorbable Stent
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs